Orforglipron: Oral GLP-1 Medicine Overview
What clinics should know about Orforglipron capsules — a non-injection GLP-1 pathway option with multiple strength tiers for titration.

Orforglipron is an oral GLP-1 pathway medicine available in the Master Pharm formulary as capsules combined with Chromium Picolinate. It provides a non-injection option for clinics building tiered weight management programs with multiple delivery formats.
Available Strength Tiers
- 0.8mg — introductory strength for protocol initiation
- 2.5mg, 5.5mg, 9mg — mid-range titration levels
- 14.5mg and 17.2mg — advanced protocol strengths
- All supplied as 30-capsule clinical packs with Chromium Picolinate
